skip to the main content area of this page

Drug Laws/Individual Listing for CHILE

Drug Laws/Individual Listing
Decree No. 867/2007 [last amended by Decree No. 416/2017] (Reglamento de la Ley No. 20.000 que Sanciona el Tráfico Ilícito de Estupefacientes y Sustancias Sicotrópicas y Sustituye la Ley No. 19.366) (sp)
2008

The primary drug law in Chile is anti-trafficking law, No. 20.000 of 2005. In August 2007, the Ministry of the Interior promulgated Decree No. 867/2007, scheduling the drugs prohibited by Law 20.000.

Article 1 of Decree 867/2007 encompasses “substances or drugs, narcotic or psychotropic,” that “create physical or psychological dependence,” and cause “serious toxic effects or considerable damage to health,” while Article 2 substances do not cause the same toxic or health effects. Article 3 refers to a schedule of precursor chemicals found in Decree No. 1358/2006.

In 2015, Chile created the National Board of New Psychoactive Substances (MNNSP), which functions as an Early Warning System and recommended the 2016 and 2017 updates described below. In December 2017, the MNNSP further recommended that 34 New Psychoactive Substances, from the synthetic cathinone, synthetic cannabinoid, tryptamine, phenylethylamine, phencyclidine, and other families, be added to Article 1 and that carfentanyl and etizolam be added to Article 2. These updates likely will be implemented in 2018.

New Psychoactive Substances, such as mPPP, were included in original Decree 867, and more new substances were added four times as of 1 May 2018. The most recent addition, Decree No. 416/2017 of September 2017, added 24 new substances to Article 1, from the synthetic cannabinoid, phencyclidine, ketamine, phenethylamine, and uncategorized families, and added fenazepam to Article 2.

In January 2016, Decree No. 1524/2015 added 48 new substances to Article 1, from the synthetic cathinone, synthetic cannabinoid, and piperazine families, and added bupropion to Article 2. The new substances additions were made after law enforcement reported detection of butilone, dimethilone, APINACA, and mCPP to the MNNSP.

In March 2015, Decree No. 1690/2014 added 51 new substances to Article 1, including 36 NBOMe compounds, DOC, DOI, PMMA, five 2C compounds, MBDB, BDB, 4-HO-DIPT, 5-MEO-DMT, 5-MEOMIPT, 5-MEO-DALT and DIPT.

In May 2009, Decree No. 324/2009 added 6 synthetic cannabinoids to Article 1: CP-47,497; CP-47,497 C-6; CP-47,497 C-8; CP-47,497 C-9; JWH-018; HU-210.


The primary drug law in Chile is anti-trafficking law, No. 20.000 of 2005. In August 2007, the Ministry of the Interior promulgated Decree No. 867/2007, scheduling the drugs prohibited by Law 20.000.

Article 1 of Decree 867/2007 encompasses “substances or drugs, narcotic or psychotropic,” that “create physical or psychological dependence,” and cause “serious toxic effects or considerable damage to health,” while Article 2 substances do not cause the same toxic or health effects. Article 3 refers to a schedule of precursor chemicals found in Decree No. 1358/2006.

In 2015, Chile created the National Board of New Psychoactive Substances (MNNSP), which functions as an Early Warning System and recommended the 2016 and 2017 updates described below. In December 2017, the MNNSP further recommended that 34 New Psychoactive Substances, from the synthetic cathinone, synthetic cannabinoid, tryptamine, phenylethylamine, phencyclidine, and other families, be added to Article 1 and that carfentanyl and etizolam be added to Article 2. These updates likely will be implemented in 2018.

 

New Psychoactive Substances, such as mPPP, were included in original Decree 867, and more new substances were added four times as of 1 May 2018. The most recent addition, Decree No. 416/2017 of September 2017, added 24 new substances to Article 1, from the synthetic cannabinoid, phencyclidine, ketamine, phenethylamine, and uncategorized families, and added fenazepam to Article 2.

 

In January 2016, Decree No. 1524/2015 added 48 new substances to Article 1, from the synthetic cathinone, synthetic cannabinoid, and piperazine families, and added bupropion to Article 2. The new substances additions were made after law enforcement reported detection of butilone, dimethilone, APINACA, and mCPP to the MNNSP.

 

In March 2015, Decree No. 1690/2014 added 51 new substances to Article 1, including 36 NBOMe compounds, DOC, DOI, PMMA, five 2C compounds, MBDB, BDB, 4-HO-DIPT, 5-MEO-DMT, 5-MEOMIPT, 5-MEO-DALT and DIPT.

 

In May 2009, Decree No. 324/2009 added 6 synthetic cannabinoids to Article 1: CP-47,497; CP-47,497 C-6; CP-47,497 C-8; CP-47,497 C-9; JWH-018; HU-210.

Decree No. 416/2017 (most current version)

Decree No. 867/2007 (page links to all versions)

Decree No. 1358/2006 (precursor chemicals)

Law No. 20.000

If you have any further information or any amendments to the information provided on this page, please send an email to Global SMART (UNODC-globalsmart@un.org).